Skip to main content
OpenTrials
Completed

NCT Number: NCT05740436

Protocol of Geriatric Rehabilitation in Patients of 60 and Older Who Live in Moscow Boarding Houses or Nursing Homes

After screening complex geriatric assessment (CGA) the participants will undergo geriatric rehabilitation programs. After termination of 21-day program, CGA will be repeated and subjects will get a program of long-term rehabilitation. A phone call in six months and a face-to-face visit in 12 months will be scheduled to follow-up and to evaluate the progress in rehabilitation.

Completed

Looking for future studies?

Notify Me

Key information

Age range

60 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Russian Research and Clinical Center for Gerontology

Moscow, 129226, Russia

About this study

After screening complex geriatric assessment (CGA) the participants will undergo geriatric rehabilitation programs. The participation duration will not exceed 13.5 months including the screening period.

The study comprises three periods:

  • screening (1-14 days)
  • a treatment course of 21 days
  • a follow-up period of 12 months On screening visit Study procedures will include
  • Informed consent signing
  • The Comprehensive Geriatric Assessment (CGA)
  • The recommendations on a program of geriatric rehabilitation based on CGA

Visit 2 will be performed at the end of rehabilitation program. It will include:

  • The abbreviated CGA
  • The evaluation of the results of 21-days geriatric rehabilitation program
  • The recommendations on a long-term geriatric rehabilitation

Visit 3 will be scheduled in 3 months after Visit 2 as a phone call. Special questionnaire will be suggested to study subjects. The questionnaire includes questions on implementation of a geriatric rehabilitation program and on quality of life

Visit 4- the last study visit will be performed in 12 months after Visit 2. It will include CGA and study completion procedures.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Men and women aged 60 and older who wanted to participate in the study and signed a consent form.
  • One or more indications for geriatric rehabilitation:
  • A discharge after a hospitalization due to an acute illness (excluding stroke and myocardial infarction), trauma, surgery, including planned ones.
  • A condition leading to an acute impairment of functional status (stress, etc.)
  • Newly admitted patients
  • Abnormalities of gait and mobility (R26)

Exclusion criteria

  • One or more contraindications to geriatric rehabilitation:
  • Severe sensory and cognitive impairment hampering rehabilitation
  • End stage diseases requiring palliative care
  • End stage frailty (bedridden patients)
  • An acute illness or an exacerbation of a chronic disease during two weeks before the enrollment in the study
  • A contradiction to any component of a rehabilitation program
  • Hearing or visual lost that can influence on study tests results
  • Refuse to participate in the study -

Treatment and study plan

Geriatric rehabilitation program based on CGA

Other

Geriatric rehabilitation program based on CGA will be performed under physicians tight control for 21 days and will include physical activity, psychological training, diet correction, adaptation measures, polypragmasia correction.

Primary outcomes

  1. functional status dynamics

    Time frame: 13 months

    Instrumental Activity Daily Life scale score

Sponsors and collaborators

Lead sponsor

Pirogov Russian National Research Medical University

Other

Registry information

Official study title

POSTSCRIPTUM: Protocol of Geriatric Rehabilitation in Patients of 60 and Older Who Live in Moscow Boarding Houses or Nursing Homes. Protocol of Multicentral Prospective Study.

Acronym: POSTSCRIPTUM

Important dates

Study start
2021
Primary completion
2023
Study completion
2024
First posted
Feb 23, 2023
Registry last updated
Jun 13, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.